Find Grants for Small Businesses (for-profit)
Find out if you qualify for verified grants for Small Businesses (for-profit). Discover your eligibility and key funding details for Small Businesses (for-profit) from major foundations and government agencies.
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: November 5, 2027
Opportunity Number: PAR-25-297
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.866
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
Deadline: March 20, 2026
Opportunity Number: PAR-25-242
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: March 20, 2026
Status: Posted
CFDA Numbers: 93.313, 93.173, 93.865, 93.989, 93.242, 93.399, 93.853, 93.286, 93.867
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-310
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-251
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-215
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Deadline: November 12, 2027
Opportunity Number: PAR-25-216
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-265
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-266
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-270
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-269
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-271
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-188
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-300
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855
Alcohol Health Services Research (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PA-25-245
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Health Services Research (R34 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-192
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Deadline: September 7, 2026
Opportunity Number: PA-25-163
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
Deadline: September 7, 2026
Opportunity Number: PAR-25-193
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-179
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-181
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-182
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-183
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-184
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-285
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-180
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-177
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
